Oregon State Public Health Laboratory Participation in the FDA NARMS Retail Meat Program

俄勒冈州公共卫生实验室参与 FDA NARMS 零售肉类计划

• 批准号: 9269038
• 负责人: John L Fontana
• 金额: $ 16万
• 依托单位: PUBLIC HEALTH SERVICES
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-01 至 2021-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9269038
• 关键词: Oregon; State; Public; Health; Laboratory

Oregon State Public Health Laboratory FDA NARMS Retail Meat Program Summary/Abstract The Oregon State Public Health Laboratory (OSPHL) plans to continue participation in the Food and Drug Administration (FDA) National Antimicrobial Resistance Monitoring System (NARMS) Retail Meat Program to provide information from active surveillance of retail meat products for microorganisms that cause foodborne illness to support epidemiological investigation and response locally and nationally. The mission of the OSPHL is to protect the health and safety of Oregonians and provide surveillance of retail meats for specific pathogens to support this goal. The OSPHL will purchase up to 80 retail meat samples per month in the metropolitan Portland area and identify bacterial isolates with microbial culture techniques. The OSPHL will send isolates of Salmonella spp., Campylobacter spp., Enterococcus spp., and Escherichia coli for antimicrobial resistance testing at the FDA. Timely information on bacterial loads on retail meat and further characterization of Salmonella spp. at the OSPHL will allow our Oregon state epidemiologists to initiate the appropriate public health response for foodborne illness outbreaks. Additional information on antimicrobial resistance may direct treatment of human cases and indicate trends to allow epidemiological intervention and evaluation of health risk. The OSPHL has participated in the FDA NARMS Retail Meat Program since 2002. We will continue to purchase retail meat products as directed by the FDA sampling program and process the meat samples utilizing the FDA protocols. All Salmonella isolates will be serotyped and characterized by pulsed filed gel electrophoresis at the OSPHL to provide comparative information with human isolates. Antimicrobial resistance testing will be performed on all isolates at the FDA and all data will be shared with state partners.

俄勒冈州公共卫生实验室 FDA NARMS 零售肉类计划摘要/摘要 俄勒冈州公共卫生实验室 (OSPHL) 计划继续参与 美国食品和药物管理局 (FDA) 国家抗菌素耐药性监测 系统（NARMS）零售肉类计划提供主动监测信息 零售肉类产品中引起食源性疾病的微生物，以支持 地方和全国的流行病学调查和应对。的使命 OSPHL 旨在保护俄勒冈人的健康和安全，并提供监测 针对特定病原体的零售肉类以支持这一目标。 OSPHL 将购买最多 每月在波特兰大都市区采集 80 个零售肉类样品并进行识别 通过微生物培养技术分离细菌。 OSPHL 将发送分离株 沙门氏菌属、弯曲杆菌属、肠球菌属和大肠杆菌 FDA 的抗菌药物耐药性测试。有关细菌负荷的及时信息 零售肉类和沙门氏菌的进一步表征。在 OSPHL 将使我们 俄勒冈州流行病学家启动适当的公共卫生应对措施 食源性疾病爆发。有关抗菌素耐药性的更多信息可能会 直接治疗人类病例并指出趋势，以允许流行病学 健康风险干预与评估。 OSPHL已参加FDA NARMS 零售肉类计划自 2002 年起。我们将继续购买零售肉类 按照 FDA 抽样计划的指示生产产品并处理肉类样品 利用 FDA 协议。所有沙门氏菌分离株都将进行血清分型和特征分析 通过 OSPHL 的脉冲场凝胶电泳提供比较信息 与人类分离物。将对所有分离株进行抗菌药物耐药性测试 FDA 和所有数据将与州合作伙伴共享。